Do you want to read an article? Please log in or register.
Keeping on the high quality of healthcare in Greek Inflammatory Bowel Disease patients in the SARS-CoV-2 era
Inflammatory Bowel Disease
Related content
Inflammatory Bowel Disease
SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group position statement
Lancet Gastroenterol Hepatol
Alexander JL, Moran GW, Gaya DR, Raine T, Hart A, Kennedy NA, Lindsay JO, MacDonald J, Segal JP, Sebastian S, Selinger CP, Parkes M, Smith PJ, Dhar A, Subramanian S, Arasaradnam R, Lamb CA, Ahmad T, Lees CW, Dobson L, Wakeman R, Iqbal TH, Arnott I, Powell N, Inflammatory Bowel Disease section of the British Society of Gastroenterology and the the Inflammatory Bowel Disease Clinical Research Group.
doi: 10.1016/S2468-1253(21)00024-8
Inflammatory Bowel Disease
Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre
United European Gastroenterol J.
Scaldaferri F, Pugliese D, Privitera G, Onali S, Lopetuso LR, Rizzatti G, Settanni CR, Pizzoferrato M, Schiavoni E, Turchini L, Amatucci V, Napolitano D, Bernabei T, Mora V, Laterza L, Papa A, Guidi L, Rapaccini GL, Gasbarrini A, Armuzzi A
doi: 10.1177/2050640620929133.
Inflammatory Bowel Disease
High Patient Activation Is Associated With Remission in Patients With Inflammatory Bowel Disease
Inflamm Bowel Dis.
Barnes EL, Long MD, Kappelman MD, Martin CF, Sandler RS
doi: 10.1093/ibd/izy378.
Inflammatory Bowel Disease
Inflammatory Bowel Diseases and Biological Treatment in SARS-CoV-2 Era. Why Not?
Inflamm Bowel Dis.
Grassia R, Soro S, Conti CB
doi: 10.1093/ibd/izaa110.
Inflammatory Bowel Disease
Illness Perception in Inflammatory Bowel Disease Patients is Different Between Patients With Active Disease or in Remission: A Prospective Cohort Study
doi: 10.1093/ecco-jcc/jjy183.
Inflammatory Bowel Disease
T cell response after SARS-CoV-2 vaccination in immunocompromised patients with inflammatory bowel disease
J Crohns Colitis
Reuken PA, Andreas N, Grunert PC, Glöckner S, Kamradt T, Stallmach A
doi: 10.1093/ecco-jcc/jjab147
Inflammatory Bowel Disease
Antibody Responses to SARS-CoV-2 After Infection or Vaccination in Children and Young Adults With Inflammatory Bowel Disease
Inflamm Bowel Dis
Dailey J, Kozhaya L, Dogan M, Hopkins D, Lapin B, Herbst K, Brimacombe M, Grandonico K, Karabacak F, Schreiber J, Liang BT, Salazar JC, Unutmaz D, Hyams JS
doi: 10.1093/ibd/izab207
Further Publications
Effectiveness of SARS-CoV-2 vaccination in a Veterans Affairs Cohort of Inflammatory Bowel Disease Patients with Diverse Exposure to Immunosuppressive Medications
Gastroenterology
Khan N, Mahmud N
doi: 10.1053/j.gastro.2021.05.044
COMMENTED
Inflammatory Bowel Disease
SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting
★ 3
Recommended and commented by
PD Dr Luc Biedermann, Faculty Member
Gut
Siegel CA, Melmed GY, McGovern DP, Rai V, Krammer F, Rubin DT, Abreu MT, Dubinsky MC, International Organization for the Study of Inflammatory Bowel Disease (IOIBD)., International Organization for the Study of Inflammatory Bowel Diseases (IOIBD).
doi: 10.1136/gutjnl-2020-324000